Towarzystwo Funduszy Inwestycyjnych PZU SA’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $359K | Sell |
1,102
-60
| -5% | -$19.6K | 0.1% | 106 |
|
|
2025
Q1 | $314K | Buy |
1,162
+160
| +16% | +$43.2K | 0.11% | 97 |
|
|
2024
Q4 | $236K | Sell |
1,002
-198
| -17% | -$46.6K | 0.08% | 110 |
|
|
2024
Q3 | $330K | Buy |
1,200
+350
| +41% | +$96.3K | 0.12% | 77 |
|
|
2024
Q2 | $207K | Hold |
850
| – | – | 0.08% | 110 |
|
|
2024
Q1 | $127K | Hold |
850
| – | – | 0.05% | 160 |
|
|
2023
Q4 | $163K | Buy |
+850
| New | +$163K | 0.07% | 113 |
|
|
2021
Q3 | $28.3K | Buy |
+150
| New | +$28.3K | 0.03% | 217 |
|